الفهرس Only 14 pages are availabe for public view
 |  | from | 190 |  |  |
| | | from | 190 | | |
Abstract
Enterococci have become in the past two decades important nosocomial pathogens after the acquisition of resistance to many commonly used antimicrobials including glycopeptides.
The most common clinical impact of vancomyin resistant enterococci (VRE) is intestinal colonization, which does not result in symptoms but may last for long periods serving as a reservoir for transmission of VRE to other patients. Patients with severe underlying diseases and immunosuppressed patients are at increased risk for infection or colonization with VRE.